S 518 108th Congress Senate Health Accreditation (Medical care) Administrative procedure Blood diseases Cardiovascular diseases Caregivers Child health Clinical trials Communication in medicine Communication in science Congress Congressional reporting requirements Cost effectiveness Department of Health and Human Services Diabetes Donation of organs, tissues, etc. Economics and Public Finance Executive reorganization Eye diseases Families

Pancreatic Islet Cell Transplantation Act of 2004

Introduced: March 5, 2003 Introduced by: Collins, Susan M. Republican · Maine See on congress.gov

Everywhere this bill has been 6 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Oct 7, 2004

Placed on Senate Legislative Calendar under General Orders. Calendar No. 773.

Oct 7, 2004

Committee on Health, Education, Labor, and Pensions. Reported by Senator Gregg with an amendment in the nature of a substitute. With written report No. 108-387.

Sep 22, 2004

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Mar 5, 2003

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Mar 5, 2003

Sponsor introductory remarks on measure. (CR S3166)

Mar 5, 2003

Introduced in Senate

Plain-English summary Congressional Research Service

Pancreatic Islet Cell Transplantation Act of 2003 - Amends the Public Health Service Act to include pancreases procured by an organ procurement organization and used for islet cell transplantation or research to be counted toward organ procurement organization certification.

Establishes the Interagency Committee on Islet Cell Transplantation within the Department of Health and Human Services (HHS). Requires the Committee to study related issues, including Federal research funding, the effect of specified policies on transplantation, and data collection.

Instructs the Secretary of HHS to request the Institute of Medicine to provide a study of the impact of islet cell transplantation on juvenile diabetes patients, including their health and the treatment's cost-effectiveness.

Directs the Secretary, acting through the Administrator of the Centers for Medicare & Medicaid Services, to establish a demonstration project to assess the efficacy of pancreatic cell islet transplantation for individuals who: (1) have Type I diabetes; and (2) have end-stage renal disease; and (3) are Medicare beneficiaries. Limits to six the number of eligible facilities that can participate in the project. Directs the Secretary to conduct an evaluation of the outcomes under the project and report to Congress. Allows the Secretary to waive such requirements of titles XI (General Provisions) and XVIII (Medicare) of the Social Security Act as are necessary to carry out the project.

Authorizes appropriations.

What's happening now October 7, 2004

Placed on Senate Legislative Calendar under General Orders. Calendar No. 773.

Committees of jurisdiction 1